OasisLMS

The HRS Board Review Course is designed to serve as a wide audience within the EP community, not only U.S. physicians preparing to recertify. It is intended to be an indispensable tool for providing a fundamentally sound EP knowledge base.

Course Highlights

Over 20 recorded didactic lectures with nine case-based workshops delivered by leading experts covering:

• Basic cardiac and intracardiac electrophysiology
• Pharmacology of antiarrhythmic drugs
• Noninvasive testing for arrhythmias
• Atrial and other supraventricular tachycardias
• Catheter ablation
• Implantable cardioverter defibrillators
• Cardiac pacing
• Intracardiac ultrasound in EP
• Transseptal catheterization techniques
• Pericardial access for epicardial mapping and ablation
• Complications of EP procedures - avoidance and management

Program Details

Welcome and Overview of Course

Module I: Basic Science and Fundamentals of Electrophysiology

• Welcome
• Basic Electrophysiology Principles for the Clinician
• Inherited Ion Channelopathies
• Sinoatrial and Atrioventricular Nodes and His-Purkinje System: Anatomy, Evaluation, Autonomics and Therapy
• Retrograde Conductions
• Workshop #1: Electrocardiographic/Electrophysiologic Correlations
  • Physiology and Conduction
  • Basic Science and Channelopathies
  • Basic Science

Module II: Invasive Diagnosis and Treatment

• Use of Overdrive Pacing/Entrainment in Supraventricular Tachycardia
• Left Atrial Appendage Occlusion
• Arrythmias in Parients with Congenital Heart Disease
• Principles of Entrainment: Ventricular Tachycardia
• Techniques of Differentiating SVT Mechanisms: Part I
• Techniques of Differentiating SVT Mechanisms: Part II
• Workshop #2: Entrainment and SVT Maneuvers
  • SVT Maneuvers Cases
  • Entrainment Cases  – VT
  • Entrainment Cases – SVT
• Catheter Ablation of Atrial Tachycardia and Typical Atrial Flutter
• Physiology, Mapping and Catheter Ablation of Accessory Pathways
• Workshop #3: SVT Mechanisms/Maneuvers
• Physiology of Catheter Ablation of AV Nodal Reentrant Tachycardia
• Special Workshop: 12 Lead ECG for PVC and VT Localization

Module III: Invasive Diagnosis and Treatment

• Ventricular Tachycardia: Ischemic and Nonischemic Cardiomyopathy and other Unique VT Syndromes
• Workshop #4: SVT and VT Invasive/Noninvasive Correlation
• Wide Complex Tachycardias: Idiopathic VTs, Bundle Branch Reentry, Antidromic Tachycardias – Mechanisms, ECG Manifestations, Invasive Assessment and Ablation
• Workshop #5: Invasive/Noninvasive Correlation

Module IV: Noninvasive Diagnosis and Treatment

• Antiarrhythmic Drugs: Part I
• Antiarrhythmic Drugs: Part II - Case Scenarios
• Workshop #6: Electrocardiographic/Electrophysiological Correlations
• Mechanisms, Pharmacologic, and Non-Pharmacologic Treatment of Atrial Fibrillation
• Biophysics of Catheter Ablation
• Workshop #7: Electrocardiographic/Electrophysiological Correlations, Atrial Fibrillation, Clinical Scenarios and Syndromes

Module V: Clinical Scenarios/Device Management

• Implantable Devices: Evaluation, Management and Troubleshooting
• Workshop #8: Device Cases
• Workshop #9: Arrhythmia Case Studies/Putting It All Together for the Board
• Testable Concepts

Module VI: Special Technology Sessions

• Transseptal Catheterization
• Complications of Electrophysiologic Studies – Avoidance and Treatment
• Use of Intracardiac Ultrasound in Electrophysiology Procedures
• Pericardial Access for Epicardial Mapping and Ablation
• Cardiac Conduction System Pacing – Theory and Practice
• This Is Not What It Looks Like...Spotting Foolers in the EP Lab
• Electroanatomical Mapping – Principles and Pitfalls

1. Describe the current guidelines related to evaluation and management of patients with cardiac rhythm disturbances
2. Describe the role of electrophysiologic testing in managing patients with brady arrhythmias and tachyarrhythmias
3. Identify the advantages and limitations of diagnostic electrophysiologic methods
4. Identify the role of pharmacologic and non-pharmacologic therapies for the treatment of arrhythmias
5. Recognize the basic electrophysiology and genetics of inherited conditions associated with cardiac arrhythmias
6. Recognize clinical, electrocardiographic, and electrophysiologic characteristics of specific cardiac arrhythmia syndromes
7. Interpret complex electrophysiologic and electrocardiographic tracings
8. Interpret stored electrograms from pacemakers and ICDs
9. Understand the role, utility and limitations of imaging (fluoroscopy, intracardiac echocardiography, electroanatomic mapping) in electrophysiologic procedures
10. Understand different methods of safely accessing left atrium with transseptal techniques, and pericardial space for electrophysiologic procedures
11. Describe potential complications of electrophysiologic procedures, how to avoid them when possible and remedy them when they occur

Clinical Cardiac EPs
Directors of EP Labs
Cardiologists
Non-US physicians preparing for EP certification exams
Physicians seeking a comprehensive overview of electrophysiology

Samuel J. Asirvatham, MD, FHRS
Mayo Clinic | Professor of Medicine and Pediatrics 

David J. Callans, MD, FHRS, CCDS
Hospital of the University of Pennsylvania

Mitchell I Cohen, MD, FHRS 
Innova Children's Cardiology | Co-Director Inova Children's Heart Center 

Abhishek J. Deshmukh, MD 
Mayo Clinic | Associate Professor 

Kenneth A. Ellenbogen, MD, FHRS
Virginia Commonwealth University Medical Center I Cardiology Chair

Edward P. Gerstenfeld, MD, FHRS
University of California, San Francisco I Professor

Mathew D. Hutchinson, MD, FHRS
Sarver Heart Center, University of Arizona I Attending Physician

Ramanan Kumareswaran, MD 
University of Pennsylvania Trustees | Clinical Electrophysiologist

Rakesh Latchamsetty, MD, FHRS 
Michigan Medicine | Associate Professor 

Barry London, MD, PhD
University of Iowa I Professor

Francis E. Marchlinski, MD, FHRS
Hospital of the University of Pennsylvania, Cardiac Electrophysiology I Professor of Medicine

Christopher J. McLeod, MBChB, PhD, FHRS
Mayo Clinic | Professor, and Director of Cardiac EP Fellowship 

William M. Miles, MD, FHRS
University of Florida I Professor of Medicine

John M. Miller, MD, FHRS
Indiana University School of Medicine I Director, Clinical Cardiac EP

Amole O. Ojo, MD, FHRS 
University of Rochester Medical Center | Attending Electrophysiologist

Jeanne E. Poole, MD, FHRS
University of Washington School of Medicine I Faculty

William G. Stevenson, MD, FHRS
Vanderbilt University Medical Center I Professor of Medicine

Gordon F. Tomaselli, MD, FHRS
Johns Hopkins University School of Medicine I Professor of Medicine

Roderick Tung, MD, FHRS
University of Chicago I Associate Professor of Medicine

Pugazhendi Vijayaraman, MD, FHRS
Geisinger Heart Institute | Director, CCEP Fellowship 

Accreditation Statement
The Heart Rhythm Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians AMA Designation Statement
The Heart Rhythm Society designates this internet enduring activity for a maximum of 34.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM Maintenance of Certification (MOC) Statement 

Successful completion of this ACE activity, which includes participation in the evaluation component, enables the participant to earn up to 34.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of ACE credits claimed for the activity. It is the ACE activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Royal College of Physicians and Surgeons of Canada MOC Recognition Statement
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “ACE in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Other Credit Available
A Credit Certificate (for physicians) or Certificate of Participation (for non-physicians) will be provided to individuals seeking credit from the following organizations which accept AMA PRA Category 1 Credit(s)™. Note that participants are advised to contact their certifying body for specific information regarding credit submissions:
·         American Academy of Family Physicians (AAFP) (for elective credit)
·         American Academy of Nurse Practitioners Certification Board (AANPCB)
·         American Academy of Physician Assistants (AAPA)
·         American Nurses Credentialing Center (ANCC)
·         American Osteopathic Association (AOA) (for Category 2 credit)
·         Committee on Accreditation of Continuing Medical Education (Canada)
·         European Board for Accreditation in Cardiology (EBAC)
·         European CME Credits (ECMEC)
·         German Chambers of Physicians
·         National Society of Genetic Counselors (for Category 2 credit)
·         Oman Medical Specialty Board
·         Qatar Council for Healthcare Practitioners
·         Royal College of Physicians and Surgeons of Canada (RCPSC)

 

ACE Disclosure Policy

The Heart Rhythm Society is committed to the provision of Accredited Continuing Education (formerly known as Continuing Medical Education (CME)) that is balanced, objective, and evidence based. HRS adheres to the Standards for Integrity and Independence in Accredited Continuing Education of the Accreditation Council for Continuing Medical Education (ACCME) which require that those individuals in a position to control the content of an educational activity (including, but not limited to, planners, faculty, authors, committee members, content reviewers, editors, and staff) disclose all financial relationships with an ACCME-defined ineligible company* within the 24 months prior to the disclosure.

 

Any individual who refuses to disclose financial relationships is disqualified from participating in HRS ACE-certified activities. Owners and employees of ACCME-defined ineligible companies may have no role in the planning or implementation of ACE activities without a special written exemption from the HRS Chief Learning Officer that will be granted only in specific circumstances that meet ACCME requirements.

All relevant financial relationships are reviewed and mitigated. 

Faculty and Reviewer Disclosures

Samuel J. Asirvatham, MD, FHRS
Honoraria/Speaking/Consulting Fee: St. Jude Medical, Medtronic, Biotronik, Boston Scientific, Biosig Technologies, MediLynx
Intellectual Property Rights: AliveCor

David J. Callans, MD, FHRS, CCDS
Honoraria/Speaking/Consulting Fee: Medtronic, Best Doctors, Biotronik, Boston Scientific, Impulse Dynamics USA, Thermedical, Biosense Webster, Inc., Baylis Medical Company, BioSig, Mediasphere Medical, Coherex, Abbott Medical
Research (Contracted Grants for PIs and Named Investigators Only): Medtronic, Boston Scientific, Biosense Webster, Inc., Biotronik, Abbott
Other Financial Relationships: Wolters Kluver (author)

Mitchell I Cohen, MD, FHRS  
Honoraria/Speaking/Consulting Fee: Alta Thera Pharmaceuticals

Abhishek J. Deshmukh, MD  
Honoraria/Speaking/Consulting Fee: GE Healthcare

Kenneth A. Ellenbogen, MD, FHRS
Honoraria/Speaking/Consulting Fee: Boston Scientific, Medtronic, Kestra, Inc., Hylomorph, Biotronik, MediLynx, Impulse Dynamics USA, Abbott, Biosense Webster, Inc., Milestone Pharmaceuticals
Royalty Income: Elsevier

Edward P. Gerstenfeld, MD, FHRS
Honoraria/Speaking/Consulting Fee: Biosense Webster, Inc., Medtronic, Abbott, Boston Scientific
Research (Contracted Grants for PIs and Named Investigators only): Biosense Webster, Inc., Farapulse

Mathew D. Hutchinson, MD, FHRS
Honoraria/Speaking/Consulting Fee: Elsevier, Medtronic, Inc.

Ramanan Kumareswaran, MD  
Honoraria/Speaking/Consulting Fee: Medtronic, Boston Scientific, Biosense Webster, Inc.

Rakesh Latchamsetty, MD, FHRS  
Honoraria/Speaking/Consulting Fee: Medtronic, Biosense Webster, Inc., Zoll Medical Corporation, Biotronik, Abbott

Barry London, MD, PhD
Nothing Relevant to Disclose.

Francis E. Marchlinski, MD, FHRS
Honoraria/Speaking/Consulting Fee: Abbott, Biotronik, Boston Scientific, Medtronic, Biosense Webster, Inc., Philips

Christopher J. McLeod, MBChB, PhD, FHRS 
Honoraria/Speaking/Consulting Fee: Biosig Technologies, Inc., AltaThera Pharmaceuticals

William M. Miles, MD, FHRS
Honoraria/Speaking/Consulting Fee: Medtronic
Fellowship Support: Medtronic, Boston Scientific, St. Jude Medical, Biosense Webster, Inc., Biotronik

John M. Miller, MD, FHRS
Honoraria/Speaking/Consulting Fee: Boston Scientific, Biosense Webster, Inc., Biotronik, BioSig, Medtronic, Abbott, Ablacon, Inc. 
Royalty Income: Elsevier
Fellowship Support: Medtronic, Boston Scientific, Biosense Webster, Inc.

Amole O. Ojo, MD, FHRS
Nothing to disclose.

Jeanne E. Poole, MD, FHRS
Honoraria/Speaking/Consulting Fee: EBR Systems
Research (Contracted Grants for PIs and Named Investigators only): Kestra, Inc., AtriCure, Inc., Biotronik
Royalty Income: Elsevier

William G. Stevenson, MD, FHRS
Stocks - Publicly Traded: Apple Inc.

Gordon F. Tomaselli, MD, FHRS
Ownership/Partnership/Principal: Domicell, LLC

Roderick Tung, MD, FHRS
Honoraria/Speaking/Consulting Fee: Abbott, AtriCure, Inc., Biotronik, Medtronic

Pugazhendi Vijayaraman, MD, FHRS
Honoraria/Speaking/Consulting Fee: Abbott, Medtronic, Biotronik, Boston Scientific
Research (Contracted Grants for PIs and Named Investigators only): Medtronic
Fellowship Support: Medtronic

The content reviewers have the following disclosures. All relevant financial relationship disclosures have been mitigated.

M. Rizwan Afzal, MD
Nothing relevant to disclose.

Andrew Berdy, MD | St. Luke’s Hospital
Nothing relevant to disclose.

Scott C. Brancato, MD, FHRS | Providence Health 
Nothing relevant to disclose.

Melanie Roberta Burg, MD, MSci | Mater Dei Hospital
Nothing relevant to disclose.

Chi Keong Ching, MBBS, FHRS | National Heart Centre Singapore 
Pfizer, Inc., Abbott, Biotronik, Boston Scientific, Biosense Webster, Inc., Medtronic, Role: Speaking and Teaching

Mitchell I Cohen, MD, FHRS  
Honoraria/Speaking/Consulting Fee: Alta Thera Pharmaceuticals

Brototo Deb, MD, MS | Georgetown University
Nothing relevant to disclose.

Ashley Greathouse, BSN, MSN, APRN | Mayo Clinic 
Nothing relevant to disclose.

David Ho, BS, MD, MS
Nothing relevant to disclose.

Ayman Hussein, MD
Boston Scientific, Relationship: Research (Contracted Grants for PIs and Named Investigators only), Role: Research

Sameer Jamal, MD, FHRS | Hackensack University Medical Center 
Impulse Dynamics Honoraria/Speaking/Consulting Fee, Role: Speaking and Teaching

David Lin, MD, FHRS | Hospital of University of Pennsylvania, Cardiology
Honoraria/Speaking/Consulting Fee: Abbott Medical, Philips

Kathy A. Loveless, DNP, ACNPC, CEPS | Advocate Health
Nothing relevant to disclose.

Thomas McGarry, MD, PhD
Nothing relevant to disclose.

John M. Miller, MD, FHRS
Honoraria/Speaking/Consulting Fee: Boston Scientific, Biosense Webster, Inc., Biotronik, BioSig, Medtronic, Abbott, Ablacon, Inc. 
Royalty Income: Elsevier
Fellowship Support: Medtronic, Boston Scientific, Biosense Webster, Inc.

James O'Hara, PhD, PAC, FHRS, CCDS | Virginia Heart
Honoraria/Speaking/Consulting Fee: Boston Scientific, Medtronic, Inc.

Amole O. Ojo, MD, FHRS
Nothing to disclose.

Rachita Navara, MD
SafeBeat RX Inc. (Research Organization), Relationship: Ownership/Partnership/Principal, Role: Ownership

Parin J Patel, MD, FHRS | Ascension St Vincent Heart Center
Honoraria/Speaking/Consulting Fee: Boston Scientific, Abbott Medical

Christopher P. Porterfield, MD, MPH, PhD, FHRS | Aurora Denver Cardiology Associates
Honoraria/Speaking/Consulting Fee: Biosense Webster, Abbott
Membership on Advisory Committees: Medtronic, Inc.

Leon Ptaszek, MD, PhD
Bristol-Myers Squibb, Relationship: Honoraria/Speaking/Consulting Fee, Role: Consulting; Pfizer, Inc., Relationship: Honoraria/Speaking/Consulting Fee, Role: Consulting; World Care Clinical Consultants, Relationship: Honoraria/Speaking/Consulting Fee, Consulting; Moderna Therapeutics, Relationship: Honoraria/Speaking/Consulting Fee, Role: Consulting, Abbott, Relationship: Honoraria/Speaking/Consulting Fee, Role: Consulting; Neutrace, Relationship: Honoraria/Speaking/Consulting Fee, Role: Consulting; Aquaheart, Relationship: Honoraria/Speaking/Consulting Fee, Role: Consulting; Neutrace: Research (Contracted Grants for PIs and Named Investigators only), Role: Research

Jorge Romero, MD
Biosense Webster, Inc., Relationship: Research (Contracted Grants for PIs and Named Investigators only), Role: Research, Comments: Investigator-initiated research study (PLEA AF trial) NCT#04216667; Organization: Sanofi, Relationship: Honoraria/Speaking/Consulting Fee, Role: Consulting; Organization: Boston Scientific, Relationship: Honoraria/Speaking/Consulting Fee, Role: Speaking and Teaching; Organization: AtriCure, Inc., Relationship: Honoraria/Speaking/Consulting Fee, Role: Board Membership

Komandoor Srivathsan, MD
Abbott Medical, Relationship: Honoraria/Speaking/Consulting Fee, Role: Speaking and Teaching

Venkatakrishna Tholakanahalli, MD
Kobara Medical Inc, Relationship: Intellectual Property Rights, Role: Consulting; St. Jude Medical, Relationship: Research (Contracted Grants for PIs and Named Investigators only), Role: Research, Comments: Research Studies , Coordinator salary support; Cardialen, Inc., Relationship: Research (Contracted Grants for PIs and Named Investigators only), Role: Research, Comments: Research coordinator salary and fellow education; Imricor, Relationship: Research (Contracted Grants for PIs and Named Investigators only), Role: Consulting, Comments: Towards Education for trainees

 

The following Heart Rhythm Society Staff have nothing relevant to disclose:

Gary Bird, PhD, MSc
Sarah Sailor, MFA
Emily Downward

The Heart Rhythm Society is committed to the provision of Accredited Continuing Education (formerly known as Continuing Medical Education (CME)) that is balanced, objective, and evidence based. HRS adheres to the Standards for Integrity and Independence in Accredited Continuing Education of the Accreditation Council for Continuing Medical Education (ACCME) which require that those individuals in a position to control the content of an educational activity (including, but not limited to, planners, faculty, authors, committee members, content reviewers, editors, and staff) disclose all financial relationships with an ACCME-defined ineligible company within the 24 months prior to the disclosure.

The Heart Rhythm Society takes steps to assure its learners and the public that the content of certified activities is accurate and reliable. The following principles are applied to the process of validating CME content. The content is peer-reviewed to ensure the following:

Fair Balance - that content is balanced among various options available for treatment and not biased toward a particular product or manufacturer.

Patient Treatment Recommendations - that patient treatment recommendations contained in the content are evidence-based, are appropriate for the target audience, and that the patient treatment recommendations contribute to overall improvement in patient care.

Scientific Validity - those scientific studies cited in the activity conform to standards accepted by the scientific community.

Learning Objectives - that the educational content supports the learning objectives of the activity, and that the objectives stated for performance-in-practice are actionable and measurable.

Omissions - that no seminal studies, data, or best evidence are missing.

ACE (formerly CME) and CoP Certificates will be awarded and available to download and print following the completion of the course and the course evaluation. Should you have any questions regarding your ACE certificate, please contact CME@HRSonline.org.